Innate Pharma - ADR

:IPHA   2:31:42 PM EDT
1.68
-0.09 (-5.17%)
: $1.74 +0.06 (+3.55%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)149.64M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.53 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$1.74
50-Day MA$1.81
200-Day MA$1.74
See more pivots

Innate Pharma - ADR Stock, :IPHA

117, Avenue de Luminy, 13 009 Marseille, Marseille, Provence-Alpes-Cote-dAzur 13009
France
Phone: +33.4.30.30.30.30
Number of Employees: 179
http://www.innate-pharma.com

Description

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv�© Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni�©, and Fran�§ois Romagn�© on September 23, 1999 and is headquartered in Marseille, France.